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Abstract: Although the applications of Proteomics in Human Biomedicine 
have been explored for some time now, in animal and veterinary research, 
the potential of this resource has just started to be explored, 
especially when companion animal health is considered.In the last years, 
knowledge on the Canis lupus familiaris proteome has been accumulating in 
the literature and a resource compiling all this information and 
critically reviewing it was lacking. This article presents such a 
resource for the first time. CanisOme is a database of all proteins 
identified in Canis lupus familiaris tissues, either in health or in 
disease, annotated with information on the proteins present on the sample 
and on the donors. This database reunites information on 549 proteins, 
associated to 63 dog diseases and 33 dog breeds. Examples of how this 
information may be used to produce new hypothesis on disease mechanisms 
is presented both through the functional analysis of the proteins 
quantified in canine cutaneous mast cell tumors and through the study of 
the interactome of Canis lupus familiaris and Leishmania infantum. 
Therefore, the usefulness of CanisOme for researchers looking for protein 
biomarkers in dogs and interested in a comprehensive analysis of disease 
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 We built and present the database CanisOme with dogs annotated proteome.  
 Proteome annotation includes quantification by disease and dog breed. 
 Dogs tryptase-P15944 is a marker candidate for immune response in tumoral process. 
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1. ABSTRACT 24 
Although the applications of Proteomics in Human Biomedicine have been 25 
explored for some time now, in animal and veterinary research, the potential 26 
of this resource has just started to be explored, especially if when companion 27 
animal health is considered. Nevertheless, Iin the last years, knowledge on 28 
the Canis lupus familiaris proteome has been accumulating in the literature 29 
and a resource compiling all this information and critically reviewing it was 30 
lacking. This article presents such a resource for the first time. CanisOme is a 31 
database of all proteins identified in Canis lupus familiaris tissues, either in 32 
health or in disease samples, annotated with information on the proteins 33 
present on the sample and on the donors. This database reunites information 34 
on 549599 proteins, associated to 58 63 dog diseases and 331 dog breeds. 35 
Examples of how this information may be used to produce new hypothesis on 36 
disease mechanisms is presented both through the functional analysis of the 37 
proteins quantified in canine cutaneous mast cell tumors and through the 38 
study of the interactome of Canis lupus familiaris and Leishmania infantum. 39 
Therefore, the usefulness of CanisOme for researchers looking for protein 40 
biomarkers in dogs and interested in a comprehensive analysis of disease 41 
mechanisms is demonstrated. 42 
Biological Significance  43 
This paper presents CanisOme, a database of proteomics studies with 44 
relevant protein annotation, allowing the enlightenment of disease 45 
mechanisms and the discovery of novel disease biomarkers for Cannis lupus 46 
familiaris. This knowledge is important not only for the improvement of animal 47 
health but also for the use of dogs as models for human health studies.   48 
 49 






1. INTRODUCTION 55 
Proteomics applications in veterinary medicine have been increasing and 56 
although single-protein concentration assessed by antibody-based affinity is 57 
still the gold standard of diagnostics for clinical practice, there is now a 58 
general agreement that a panel of independent disease-related proteins could 59 
substantially improve the diagnosis of animal diseases. In particular, farm 60 
animals’ proteomic approaches have been explored and recently reviewed 61 
[1,2]. Comparatively to farm animals, other companion animal species such 62 
as Canis lupus familiaris have not had their proteomes as well studied in a 63 
large scale, and most studies using proteomic approaches are focused on 64 
studies of infectious [3–7] and neoplasic disease [8–15], in particular.  65 
One of the reasons for the scarcity of proteomics research on dog diseases, 66 
when compared to farm animals, is certainly the importance of the latter as 67 
economic resources. Additionally, when compared to rodents and humans, 68 
the information on the genetics and proteomics of companion animals such as 69 
the dog, is much less abundant, which makes the effective use of this 70 
information for diagnostics much more difficult.  However, bBetter biomarkers 71 
are urgently needed in veterinary medicine of companion animals for 72 
diagnosis and prognosis of diseases [16].  73 
Dogs are affected by a large number of diseases, some specific of Canis 74 
lupus familiaris, others affecting their human partners, and therefore dogs 75 
may serve as models of human conditions [17]. There are several examples 76 
which have been reviewed previously [17,18], most notably cancer [19–21], 77 
neurological [22] and cardiac diseases [23]. In fact, it is has been proposed 78 
that some human adaptations to the environmental shifts, that contribute 79 
(through antagonistic pleiotropy) to disease, such as highly reactive immune 80 
systems that protects from infectious disease, but predispose individuals to 81 
autoimmune disorders, might have evolved in parallel in dogs [24]. 82 
Additionally, it is known that different dog breeds are affected by different 83 
diseases [25] and knowledge of the risk of breed specific breed diseases is 84 
very useful in developing a differential diagnosis list, compatible with clinical 85 
 4 
signs presented by the patient. However, presently most of the knowledge is 86 
clinical and mainly not largely based on molecular data underlying the 87 
physiological and pathological changes present in disease. The development 88 
of new diagnostic strategies and personalized therapeutic regimens depends 89 
on the generation and interpretation of molecular data which reflect the clinical 90 
changes associated with disease and treatment. The Omics sciences have a 91 
determinant role in the generatingon of these data, as has been the case in 92 
human health. In fact, the a systems approach enabled by the use of Omics 93 
data, allows for the complete catalogue and a wider screening of molecules, 94 
which is more effective in biomarker discovery, than studies directed at one or 95 
a few molecules. In the last years, some studies reporting molecular data 96 
relative to the different dog breeds diseases have been published [25], but 97 
information is largely dispersed and lacking a functional interpretation 98 
underpinned by the clinical and physiological data. The great amount of data 99 
generated by the Omics sciences, however, can only be explored and 100 
conjugated with other data using bioinformatics tools and databases.  101 
There are few databases specifically dedicated to dogs. Examples are a 102 
database with the mitochondrial genome for Canis lupus familiaris 103 
(http://clf.mtdna.tree.cm.umk.pl/) [26] and the database DoGSD 104 
(http://dogsd.big.ac.cn), that focuses on whole genome SNP data from 105 
domesticated dogs and grey wolves [27]. THowever, there are also molecular 106 
databases which include genetic information for Canis lupus such as the 107 
Ensemble (http://www.ensembl.org/Canis_familiaris/Info/Annotation) and 108 
NCBI Entrez databases 109 
(http://www.ncbi.nlm.nih.gov/projects/mapview/static/dogsearch.html) where 110 
the dog genomes are available. Furthermore, because dogs are genetic 111 
model species, there are databases with specific SNP-STR/microsatellite 112 
compound markers in dog, along with other model species 113 
(http://www.sbg.bio.ic.ac.uk/~ino/SNPSTRdatabase.html) [28] and the IPD: 114 
the Immuno Polymorphism Database (http://www.ebi.ac.uk/ipd/) which is 115 
included in a set of specialist databases related to the study of polymorphic 116 
genes in the immune system of several animals, including dogs [29]. 117 
As far as proteomics databases, Cannis lupus familiaris reference proteome 118 
deposited in Uniprot is based on the genome and not experimentally derived. 119 
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In fact, the complete annotation of the protein-coding and non-protein-coding 120 
gene sets of the 2005 published genome is still on-going. The dog genome 121 
has 39 chromosomes containing 2.4 Gb and an estimate of 25,000 protein-122 
coding genes of which only 812 have been reviewed so far (September 2015). 123 
http://www.uniprot.org/proteomes/UP000002254. 124 
A database gathering all the information generated by proteomics analysis of 125 
Canis lupus familiaris samples and associated information, such as the ones 126 
existing for humans (Human protein reference database 127 
(http://www.hprd.org/index_html) [30], Human Proteinpedia 128 
(http://www.humanproteinpedia.org/)[31] and OralCard 129 
(http://bioinformatics.ua.pt/OralCard/)[32,33]) is still lacking. The aim of this 130 
paper is to present such a resource which allows for the functional 131 
interpretation of the proteomic data. This study and the associated database, 132 
enables the integrated interpretation of proteomics data from various tissue 133 
and fluid samples of Canis lupus familiaris, and is a fundamental tool for 134 
biomarker identification and the development of innovative molecular 135 
diagnostic strategies.  136 
 137 
2. MATERIALS & METHODS 138 
2.1. Compilation and curation of CanisOme database 139 
To create the CanisOme database the first step was to compile all the 140 
information produced by proteomics studies focused on finding specific 141 
proteins altered in diseases of different breedsbreed’s diseases of Canis 142 
lupus familiaris. Bibliographic references of proteomic studies in which a 143 
complete list of proteins was provided were analysed and thirtyforty-seven 144 
three articles published between 2005 and 2015 [3–15, 34–57] were included. 145 
These studies used samples from different sources which are annotated in 146 
Table 1.  147 
In this database, each protein (identified by its UniProtKBAC) is annotated 148 
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with its name, the dog breed, the sample type and the technique used for 149 
protein identification. Further annotation includes the sample donor 150 
information such as healthy or diseased (in which case the disease is 151 
identified), age, gender and gonadectomy status. When the protein entry 152 
corresponds to a sample from an individual with an infectious disease, the 153 
type of microorganism (virus, bacteria or parasite) and its species are 154 
annotated in the column OrganismMicroorganism. When available, the data 155 
on that protein’ss’ quantification is also registered, either as a fold change 156 
value or as an up or down regulated protein., and iI If the protein has already 157 
been suggested as a biomarker that is also annotated. Finally, the source of 158 
information for that entry is inserted as a PMID, as well as the year of 159 
publication. 160 
The curated list of proteins identified in this work was stored in the database 161 
CanisOme developed for this purpose 162 
(http://www.crb.ucp.pt/salivatec/canisome/).   163 
 164 
2.2. Canis lupus familiaris proteome analysis 165 
 2.2.1. Gene Ontology (GO) analysis 166 
For this work, Pproteins of CanisOme are were further annotated with the 167 
plug-ins ClueGo [58] and CluePedia [59] for Cytoscape [60]. The enrichment 168 
analysis of the biological processes in which Canis lupus familiaris proteins 169 
participate and which are compromised in all the diseases reflected are were 170 
identified.  171 
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All Results were created with ClueGO v2.2.3 + CluePedia V1.2.3, using the 172 
Ontology GO_BiologicalProcess-Custom_07.12.2015_15h48 selecting the 173 
options: 174 
 GO Fusion = true;  175 
GO Group = true; 176 
 Kappa Score Threshold = 0.4;  177 
 Over View Term = SmallestPValue 178 
; Group By Kappa Statistics = true; 179 
 Initial Group Size = 1 and  180 
Sharing Group Percentage = 50.0. 181 
The Statistical Test used was Enrichment/Depletion (Two-sided 182 
hypergeometric test) corrected with Bonferroni step down. 183 
The ontology “GO Biological Process” dated 30.06.2015, was used. The 184 
option “Use GO Term Fusion” and an alpha value of 0.05. 185 
 2.2.2. Disease Association analysis 186 
Canis lupus familiaris proteins were scrutinized for their involvement in 187 
diseases using Uniprot Retrieve Tool [61]. 188 
The prevalence of diseases for each breed followed the classification 189 
proposed by Dorn 2002 [25] in which each disease has an odds ratio defined 190 
as the risk (odds of diagnosis) of disease X in breed Y as compared to the risk 191 
(odds of diagnosis) of disease X in all other breeds of dogs combined.  192 
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The choice of canine cutaneous mast cell tumors, for and in depth analysis, 193 
was based on the fact that this is the disease in which a larger number of 194 
proteins (mainly exclusive one) were identified and quantified.  195 
The functional analysis of the proteins involved in this disease was done using 196 
STRING  v10 - Search Tool for the Retrieval of Interacting Genes/Proteins 197 
[62], using in Action View to visualize the effect of each protein in a Protein-198 
Protein Interaction (PPI) with high confidence (0.4 score). The STRING 199 
Enrichment Tool was used to catalogue each protein about relative to the GO 200 
Cellular Components. 201 
2.3. Host-pathogen interactomics 202 
The PPIs established between Leishmania infantum proteins and Canis lupus 203 
familiaris was performed using the OralInt V2.0 tool developed by our group 204 
[63] which allows for the prediction of interspecies PPIs. The input for this 205 
analysis were the 16 dog proteins associated to Leishmaniosis in CanisOme 206 
database and the Leishmania infantum proteome deposited in Uniprot as of 207 
May 2015. Only high confidence PPIs were considered (score≥0.9). A 208 
network of the predicted PPIs was generate and visualized using the 209 
Cytoscape software [60] was used to visualize the PPI network.  210 
 211 
3. RESULTS AND DISCUSSION 212 
The congregation joining of information generated by the Omics sciences in 213 
electronic platforms, which enable a simple and efficient search, provides 214 
useful tools for the identification of protein signatures and the discovery of the 215 
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role these proteins play in the molecular mechanisms underlying different 216 
diseases. The information provided by this analysis can be used to find new 217 
diagnostic and therapeutic solutions. 218 
CanisOme is a database that integrates the information produced by 219 
proteomics or studies focused on finding specific proteins altered in diseases 220 
of different breeds of Canis lupus familiaris 221 
(http://www.crb.ucp.pt/salivatec/canisome/).  222 
When the information included in CanisOme is compared with the other 223 
proteome database with information on Canis lupus familiaris (UNIPROT) it 224 
can be seen that it has manually reviewed information on 599 549 proteins 225 
(Figure 1), whereas Uniprot has information on only 219 222 proteins 226 
identified at the protein level and 44 46 proteins with un-reviewed information 227 
(a total of 263 268 proteins with evidence at the protein level). It can thus be 228 
concluded that CanisOme is the largest repository of information on proteins 229 
identified in Canis lupus familiaris , not only because it has the largest number 230 
of proteins identified at the protein level, but also because each protein is 231 




Figure 1. Comparison of the protein number and type of evidence for protein 235 
existence for the Canis lupus familiaris proteome deposited in the Uniprot and 236 




When the 5499 proteins of CanisOme are annotated with the applications 239 
ClueGo and CluePedia for Cytoscape, the different biological processes in 240 
which they participate are identified (Figure 2). Biological processes such as 241 
regulation of endopeptidase activity, symbiosis encompassing mutualism 242 
through parasitism, oxoacid metabolic process the negative regulation of 243 
programmed cell death, platelet activation, the complement activation and 244 




Figure 2. Enrichment analysis of the biological processes in which Canis 249 
lupus familiaris proteins participate. Analysis done using the 250 
CluePedia+ClueGo plugins for Cytoscape. Processes marked with ** denote 251 
a significant enrichment at the alpha=0.05 level. 252 
 253 
Of the 5499 proteins listed in CanisOme, 11124 are identified only in health 254 
and 428 388 are present in samples from healthy and diseased donors. 255 




samples. Figure 3 shows the number of proteins with quantitative and 257 
qualitative data in health, disease and both health and disease. From In figure 258 
3 it is possible to verify that the larger number of proteins identified are 259 
present both in health and disease (42388) and that the most quantitative 260 
data are relative to the disease caused by the influenza virus (276). For rabies, 261 
36 proteins were identified and these are counter regulated, meaning that are 262 







Figure 3. Proteins annotated in CanisOme regarding their involvement in 268 
health, disease or both. ↑ and ↓ represent up and downregulated proteins 269 
respectively. * denotes proteins up or down regulated more than threefold 270 
after exercise, ** represents counter regulated proteins all found in rabies 271 
(furious and paralytic stages) and *** represents denotes proteins which are 272 
only referred as to being up or down regulated but haven´t been quantified in 273 
influenza virus infection.  274 
 275 
The 599 549 proteins of CanisOme represent 58 63 diseases of which, the 276 
four with more altered proteins identified are, in addition to the canine 277 
influenza virus A (276), Duchenne muscular dystrophy (834), rabies (346) and 278 
meningoencephalitis (345). 279 
Table 1 presents the main information present in CanisOme regarding 280 
disease distribution by breed. For each disease the number of associated 281 
proteins, as well as the biological sample used for diagnosis is presented. 282 
Also for each disease, the number of proteins which are identified exclusively 283 
in that disease, and therefore present the greatest potential for diagnostic 284 
purposes, are indicated. As an example it is possible to verify in the 285 
CanisOme database that for Duchenne muscular dystrophy 83 proteins were 286 
identified in Golden Retrievers and 23 proteins (UniProt ID: Q863Z4/ 287 
Myotrophin,  and UniProt ID: F6X7L07/ Tropomyosin 4, and UNIPROT ID: 288 
F1PV45/ Titin) were only identified in this disease.   289 
The comparison of the information available in CanisOme with the information 290 
on the most prevalent diseases in each dog breed published by Dorn in 2002 291 
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[25] shows that there is scarce information on the most prevalent diseases as 292 
far as proteomics studies. There are proteomics data on two prevalent dog 293 
diseases: obesity in Beagles and lethal acrodermatitis in Bull terrier (Table1). 294 
This The analysis by breed is hampered by the fact that some authors of 295 
proteomics studies do not refer the dog breed used in the study or refer to the 296 
use mixed breed donors as mixed breeds (Table 2). Some other studies use 297 
pooled samples from different breeds [37,43]. That is the reason why in table 298 
1 these diseases are annotated with the same information for all the breeds 299 
contributing to the sample pool. 300 
Table 1 – Proteins present in CanisOme classified by dog breed, the tissue 301 
from which they originated and their association with disease. Proteins 302 
marked with an* have been classified by Dorn 2002 [25] as being more 303 
prevalent in the breed indicated, when compared to other breeds.  304 
 305 











Meningoencephalitis  34   1 Cerebrospinal fluid 





1 Cerebrospinal fluid 
Canine influenza 















10   0 Urine 
Australian 
shepherd 
Lymphoma 5   5 
Lymph nodes and 
plasma 





mast cell tumors  






Various cancers 5 1 3 Tears 
Brazilian fila Various cancers 5 1 3 Tears 
Cairn terrie 
Prostatic carcinoma 2   2 Prostate 
Chronic bronchitis 7  6 
Bronchoalveolar 
lavage fluid 
Chihuahu as Meningoencephalitis 34   1 Cerebrospinal fluid 
Dachshund 
Canine cutaneous 
mast cell tumours 
13 6 13 Skin 
Dalmatian Lymphoma 5   5 


















Breast cancer  5 
 
5 Serum 
Various cancers 5 1 3 Tears 





20   0 Serum 
Prostatic carcinoma 2 
 
2 Prostate 
Chronic bronchitis 7  6 
Bronchoalveolar 
lavage fluid 
Malteses Meningoencephalitis 34   1 Cerebrospinal fluid 
Miniature pinscher Various cancers 5 1 3 Tears 
Newfoundland Lymphoma 5   5 
Lymph nodes and 
plasma 









Lymph nodes and 
plasma 




Prostatic carcinoma 2   2 Prostate 
Various cancers 5 1 3 Tears 




10   0 Urine 
Shar-pei 
Canine cutaneous 
mast cell tumours 
13 6 13 Skin 




mast cell tumours 
13 6 13 Skin 
Viszla Various cancers 5 1 3 Tears 
Weimaraner 
Canine cutaneous 
mast cell tumours 
13 6 13 Skin 
Various cancers 5 1 3 Tears 
Yorkshire terriers Meningoencephalitis  34   1 Cerebrospinal fluid 
Pit bull 
Canine cutaneous 
mast cell tumours 
13 6 13 Skin 














Table 2 lists the diseases for which exclusive proteins (proteins found only in 307 
that disease) were identified, as well as the reduced number of proposed 308 
biomarker proteins. Unfortunately, not only is the number of proposed 309 
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biomarkers low, but also, for the most prevalent diseases, there are no 310 
biomarkers proposed. 311 
 312 











Allergies 10 6     
Alzheimer’s disease 1 1     
Breast cancer 12 2  X 
Canine babesiosis 15 1 X   
Canine cardiopulmonary dirofilariosis 7 1     
Canine inflammatory bowel disease 8 5     
Canine leishmaniasis 16       
Intervertebral disc herniation 1 1 X   
Lymphoma 5       
Osteoarthritis 15 8   X 
Prostatic carcinoma 2       
Renal insufficiency 1 1 X   
Transitional cell carcinoma 10       
Various cancers 4 1   X 
XLHN 14 4   
Duchenne muscular dystrophy 1  X  
Envenomation by European adder 





Joint osteoarthritis secondary to 






*According to Dorn 2002 [25]. 
 315 
Data in the CanisOme database shows that, up to the moment, protein 316 
biomarkers have been proposed only for renal insufficiency (UniProt 317 
ID: E2RCE0/ Cystatin C, up-regulated), intervertebral disc herniation (UniProt 318 
ID: Q6YKA4/ High-mobility group box 1, up-regulated), Duchenne muscular 319 
dystrophy (UNIPROT ID: F1PV45/ Titin) and canine babesiosis (UniProt 320 
ID: P51742/ TNF-α). However, because the studies leading to this these 321 
proposals were done on mixed breeds or in unmentioned breeds, it is not 322 
possible to associate this information with the breeds presented on table 1. 323 
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The analysis of the distribution of the 5499 proteins of CanisOme by biological 324 
sample (figure 4) shows that fluids such as saliva have led to the identification 325 
of 122 111 proteins, whereas 113 67 proteins were identified in serum, 87 94 326 
in urine, 378 in cerebrospinal fluid and 74 in plasma. Figure 4 shows which 327 
salivary proteins can be found for each type of dog biological sample when 328 
the human homolog proteins are considered. Because a significant number of 329 
proteins is potentially found in saliva, we can propose this fluid, which can be, 330 
obtained in a noninvasive manner, as a good alternative to other fluids in 331 
future proteomics studies in dog.  332 
 333 
 334 
Figure 4. Total number of proteins in biological samples deposited in the database 335 
CanisOme and the homologous proteins previously identified in human saliva 336 
according to OralCard. 337 
 338 
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One of the conditions disease biomarker candidate proteins must fulfill are to 339 
be altered only in that disease or to be up/down regulated relative to their 340 
expression in health. In table 1 we noted that the disease with the largest 341 
number of exclusive proteins is canine cutaneous mast cell tumors with 13 342 
proteins identified and quantified of which 6 are exclusive. The names and the 343 
gene name used by STRING [62] of the 13 proteins referred are presented in 344 
Table 3. Figure 5 shows how the proteins identified as altered in canine 345 
cutaneous mast cell tumors diseaseome are organized in networks, 346 
establishing functional relationships.  347 
Table 3. – Attributes and regulation details for proteins deposited in 348 
CanisOme associated with cCanine cutaneous mast cell tumors. ↑ and ↓ refer 349 
to up and down regulated proteins respectively. 350 
Uniprot KB 
AC 
Gene Name Protein name Regulation Exclusive 
E2R0L9 TCP1 T-complex protein 1, alpha subunit ↑ × 
E2RB81 CCT5 T-complex protein 1, epsilon subunit ↑ × 







F1PR93 WDR1 WD repeat domain 1 ↑ × 
E2RAU5 HSPA9 




E2RCI8 ANXA6 Annexin A6 ↑  
E2RD86 PDIA3 







Tryptase alpha/beta 1 ↓ × 
J9P430 TF Transferrin ↓  
O18840 ACTB Actin, beta ↓  
P49822 ALB Serum albumin ↓  
Q6TEQ7 ANXA2 Annexin A2 ↓  
 351 
Nine of the proteins form a larger network, two2 other proteins, in spite of 352 
interacting (evidence from text mining and co-expression, not shown), it is not 353 
known the functional nature of the interaction is not known and 2 other 354 
proteins do not interact with any other in the group (figure 5). Of the 13 355 
proteins, 10 can be present in exosomes (Figure 5), and therefore contribute 356 
to extracellular communication. Of the exclusive proteins listed on Table 3, the 357 
tryptase (UniProt ID: P15944) is the major neutral protease present in mast 358 
cells and is secreted upon the coupled activation-degranulation response of 359 
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these cells. T, this protein is down-regulated, therefore it may be an 360 
interesting candidate as a marker for the role of immune response in tumoral 361 
processes. 362 
 363 
Figure 5. Protein-protein interactions determined by STRING V10 using the 364 
Action View and the Enrichment Tool for GO Cellular Components to find 365 
which of the 13 proteins associated with canine cutaneous mast cell tumors 366 
were identified in exosomes (proteins colored in red). Up regulated (↑) and 367 
down regulated (↓) proteins. Blue edges represent binding and black edges 368 
with circles undirected interactions. 369 
 370 
Canine leishmaniosis caused by the parasite Leishmania infantum, is a 371 
systemic disease with variable clinical signs that is endemic in the 372 
Mediterranean countries and for which dogs are the main domestic reservoir 373 
of the parasite. The immune mechanisms underlying the lack of disease 374 
resolution are not completely known, however it is well established that the 375 
effective immune response to the parasite is cell mediated and depends on a 376 
Th1/ Th2 response [64]. Th1/IFNγ secreting cells that also produce IL2 377 
activate the infected macrophages to kill Leishmania, whereas Th2/IL4 378 
secreting cells divert the immune response to humoral immunity and down 379 
regulation of cellular immunity with Th1 cell anergy.  380 
Although proteomics data for this pathology are scarce, with only 16 proteins 381 
identified as being altered and only 4 of them quantified, we can study the role 382 
of these 16 proteins present in CanisOme with OralInt [63] for the 383 
determination of interspecies interactome. This analysis allows for the 384 
identification of the predicted PPI interactions of dogs and Leishmania 385 
infantum proteins. Figure 6 represents the interaction with a combined score ≥ 386 
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0.9 (very high confidence), and shows 176 interactions involving 10 dog 387 
proteins and 153 Leishmania infantum proteins. 388 
 389 
 390 
Figure 6. Partial network of the Canis lupus familiaris/Leishmania infantum 391 
interactome generated by the OralInt algorithm and visualized in Cytoscape. 392 
Canis proteins are represented by diamonds, Leishmania proteins are 393 
represented by rectangles.  394 
 395 
Of the interactions in figure 6 the most interesting, due to its functional 396 
meaning, is the PPI between the Interleukin-2 receptor (UniProt ID: P40321), 397 
which is up regulated in the diseased animal, and the parasite’s protein 398 
serine/threonine-protein phosphatase (UniProt ID: A4I1H6) (both proteins are 399 
colored red in the figure). 400 
It is documented that Leishmania can activate several molecules that inhibit 401 
intracellular signaling cascades, including the activation of the host protein 402 
phosphatases (PTP) by the parasite’s´ gp63 protease [65,66]. An important 403 
negative regulatory molecule is the PTP SHP-1, which is expressed mainly in 404 
hematopoietic host cells. The SHP-1 is able to bind to an evolutionarily 405 
conserved immune receptor tyrosine-based inhibitory motif (ITIM)-like motif 406 
found in the kinase domain of IL-1 receptor-associated kinase 1 (IRAK-1), 407 
causing its inactivation [67].  408 
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It was demonstrated that macrophage PTP activity is activated very rapidly, 409 
when exposed to Leishmania donovani promastigotes, which is correlated 410 
with a rapid, general tyrosine dephosphorylation of high-molecular-weight 411 
proteins [65]. Our analysis suggests that the intracellular dephosphorylation in 412 
macrophages may occur via the parasites serine/threonine-protein 413 
phosphatase (UniProt ID: A4I1H6), which should be tested and verified 414 
experimentally. As far as we know, this is the first time such a mechanism of 415 
macrophage parasite response inhibition is proposed. Furthermore, one of the 416 
dog’s proteins with the most interactions (labeled in Orange in figure 6) is a 417 
nucleoside diphosphate kinase (Ndk) (UniProt ID: Q50KA9) with 418 
serine/threonine-specific protein kinase activity and histidine protein kinase 419 
activity, among others (Uniprot) [61]. Therefore, it may also be responsible for 420 
alterations of the phosphorylation mechanism occurring in the macrophages, 421 
if its functions are compromised by the unspecific binding/interaction/inhibition 422 
to many L. infantum proteins, as the results from the OralInt analysis suggests. 423 
Microbial Ndks have been related to virulence and subversion of immunity via 424 
purinergic signaling [68]. Furthermore, the disruption of the enzyme’s´ function 425 
in human hosts has been related to enhanced metastatic potential [69], to the 426 
endocytic caveolae stability and complex formation with G-proteins [70]. Dogs 427 
Ndk (UniProt ID: Q50KA9) may be affected by the Leishmania infantum 428 
proteins in a similar fashion, disrupting the host cells metabolism, contributing 429 
to the infection. A quantification of this protein will be fundamental to enlighten 430 
this aspect of the of dog and /parasites´ interaction. 431 
 432 
3. CONCLUSION 433 
The gathering of information relative to the Canis lupus familiaris proteome, 434 
as demonstrated in the different examples and strategies presented, is a 435 
useful tool useful for the search of mechanisms associated to different dog 436 
diseases. Therefore, as more proteomics studies are published, CanisOme 437 
may develop into an important tool in biomarker identification for diagnostic 438 
purposes and disease mechanism proposal.  439 
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Canine influenza virus A (H3N2) 276 276 Lung
Bull terrier Lethal acrodermatitis* 12 6 5 Liver
Golden retriever Duchenne muscular dystrophy 83 2 83 Muscle




Chronic bronchitis 7 6
Bronchoalveolar 
lavage fluid
Canine cutaneous mast cell tumors 13 6 13 Skin
Multicentric lymphoma 20 0 Serum
Various cancers 5 1 3 Tears
Brazilian fila Various cancers 5 1 3 Tears
Prostatic carcinoma 2 2 Prostate
Chronic bronchitis 7 6
Bronchoalveolar 
lavage fluid
Chihuahu as Meningoencephalitis 34 1
Cerebrospinal 
fluid
Dachshund Canine cutaneous mast cell tumours 13 6 13 Skin
Dalmatian Lymphoma 5 5
Lymph nodes 
and plasma
Doberman pinscher Various cancers 5 1 3 Tears
English cocker 
spaniel
Various cancers 5 1 3 Tears
Canine leishmaniasis 16 4
Serum and 
saliva
Multicentric lymphoma 20 0 Serum
Breast cancer 5 5 Serum
Various cancers 5 1 3 Tears
Irish setter Various cancers 5 1 3 Tears
Multicentric lymphoma 20 0 Serum
Prostatic carcinoma 2 2 Prostate
Chronic bronchitis 7 6
Bronchoalveolar 
lavage fluid
Malteses Meningoencephalitis 34 1
Cerebrospinal 
fluid
Miniature pinscher Various cancers 5 1 3 Tears
Newfoundland Lymphoma 5 5
Lymph nodes 
and plasma
Pekingeses Meningoencephalitis 34 1
Cerebrospinal 
fluid




Chronic bronchitis 7 6
Bronchoalveolar 
lavage fluid























Alzheimer’s disease 1 1
Breast cancer 12 2 X
Canine babesiosis 15 1 X
Canine cardiopulmonary dirofilariosis 7 1
Canine inflammatory bowel disease 8 5
Canine leishmaniasis 16
Intervertebral disc herniation 1 1 X
Lymphoma 5
Osteoarthritis 15 8 X
Prostatic carcinoma 2
Renal insufficiency 1 1 X
Transitional cell carcinoma 10
Various cancers 4 1 X
XLHN 14
Duchenne muscular dystrophy 1 X
Envenomation by European adder 
(Vipera berus berus)
5
Joint osteoarthritis secondary to 
cranial cruciate ligament disease
17
*According to Dorn 2002 [25].
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Uniprot KB AC String Code Protein name Regulation Exclusive
E2R0L9 TCP1 T-complex protein 1, alpha subunit ↑ ×
E2RB81 CCT5 T-complex protein 1, epsilon subunit ↑ ×






F1PR93 WDR1 WD repeat domain 1 ↑ ×
E2RAU5 HSPA9 Heat shock 70 kDa protein 9 (mortalin) ↑
E2RCI8 ANXA6 Annexin A6 ↑
E2RD86 PDIA3 Protein disulfide isomerase A3 ↑
P15944 ENSCAFG00000031939 Tryptase alpha/beta 1 ↓ ×
J9P430 TF Transferrin ↓
O18840 ACTB Actin, beta ↓
P49822 ALB Serum albumin ↓
Q6TEQ7 ANXA2 Annexin A2 ↓
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